Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT

Aurinia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
53M 66.43M 83.43M 37.14M 33.41M 64.46M 48.88M 46.4M 81.71M 89M 94.17M 86.05M 151.63M 132.54M 231.9M 57.59M 121.56M 156.59M
Short-Term Investments
262.13M 246.47M 275.04M 311.61M 297.07M 255.45M 301.61M 291.5M 269.01M 272.53M 295.22M 290.59M 240.1M 286.21M 234.18M 228.81M 197.18M 191.67M
Long-Term Investments
n/a n/a n/a n/a 199K 199K 201K 591K n/a 22.68M n/a n/a n/a n/a n/a n/a 5M 12.6M
Other Long-Term Assets
93K 823K 823K 868K 867K 1.5M 1.52M 1.52M 1.52M 13.36M 13.34M 13.05M 12.36M 11.84M 11.84M 11.84M 11.86M 11.86M
Receivables
40.09M 40.35M 36.54M 36.48M 25.52M 28.91M 24.09M 37.95M 19.5M 19.05M 13.48M 41.77M 18.17M 20.4M 15.41M 9.81M 4.42M 1.19M
Inventory
46.5M 46.2M 39.23M 38.71M 38.85M 39.76M 39.7M 32.82M 33.16M 31.75M 24.75M 25.32M 25.86M 26.27M 19.33M 19.29M 17.38M 15.94M
Other Current Assets
665K 781K 1.13M 16.52M 6.98M 2M 1.03M 1.65M 1.21M 1.23M 1.33M 3.81M 1.09M 3.97M 796K 728K 886K 1.18M
Total Current Assets
408.97M 405.76M 446.6M 440.46M 409.67M 398.22M 424.8M 426.47M 415.91M 423.65M 442.54M 459.7M 453.19M 477.62M 513.32M 329.22M 349.69M 372.25M
Property-Plant & Equipment
89.45M 94.11M 98.87M 103.53M 108.18M 111.95M 116.57M 121.17M 125.79M 8.65M 8.56M 8.7M 9.26M 9.56M 9.8M 10.08M 10.43M 10.52M
Goodwill & Intangibles
4.05M 4.16M 4.36M 4.51M 4.62M 4.76M 4.98M 5.26M 5.68M 6.1M 6.42M 6.84M 7.34M 7.88M 8.4M 8.93M 9.29M 9.85M
Total Long-Term Assets
93.59M 99.09M 104.05M 108.9M 113.86M 118.41M 123.26M 128.54M 132.99M 28.11M 28.32M 28.59M 28.95M 29.28M 30.04M 30.85M 36.58M 44.83M
Total Assets
502.56M 504.85M 550.64M 549.36M 523.53M 516.63M 548.06M 555.01M 548.9M 451.76M 470.86M 488.29M 482.15M 506.9M 543.37M 360.07M 386.27M 417.08M
Account Payables
3.31M 4.22M 5.19M 8.88M 8.41M 5.67M 4.33M 8.85M 4.81M 3.68M 3.09M n/a n/a 3.27M 3.88M 3.26M 2.54M 2.18M
Deferred Revenue
5.5M 4.59M 11M 4.3M 4.37M 4.91M 4.81M 4.66M 3.23M 3.16M 3.15M n/a n/a n/a 31.07M 26.71M 23.3M 15.51M
Short-Term Debt
n/a n/a 15.07M n/a 14.91M n/a 15.6M 14.31M 14.97M n/a n/a 918K 953K n/a n/a 1.11M 1.11M 1.07M
Other Current Liabilities
2.54M 1.7M 66.5M 790K 22.2M 32.93M 13.7M 13.36M 9.48M 21.48M 18.15M 23.35M 19.45M 19.95M 17.47M 5.34M 1.26M 1.31M
Total Current Liabilities
78.27M 68.41M 97.76M 78.61M 76.9M 71.05M 77.19M 73.89M 61.66M 42.05M 46.11M 41.77M 34.63M 33.84M 40.65M 37.54M 29.32M 21.15M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
12.03M 11.44M 11.11M 10.84M 10.94M 12.29M 10.91M 10.34M 8.71M 12.32M 12.17M 15.83M 16.32M 17.38M 15.95M 16.56M 16.87M 17.89M
Total Long-Term Liabilities
89M 86.25M 75.4M 82.75M 82.01M 86.11M 92.92M 89.25M 94.95M 19.31M 19.32M 23.1M 23.75M 24.94M 23.63M 24.36M 24.7M 25.7M
Total Liabilities
167.26M 154.66M 173.17M 161.36M 158.91M 157.16M 170.11M 163.14M 156.61M 61.35M 65.42M 64.87M 58.38M 58.78M 64.28M 61.89M 54.01M 46.85M
Total Debt
81.83M 77.91M 79.37M 87.85M 85.98M 88.54M 97.61M 93.21M 101.21M 7.93M 8.09M 8.19M 8.38M 8.57M 8.74M 8.91M 8.94M 8.88M
Common Stock
1.12B 1.16B 1.19B 1.21B 1.21B 1.21B 1.2B 1.2B 1.2B 1.19B 1.19B 1.18B 1.18B 1.18B 1.18B 967.16M 954.57M 952.67M
Retained Earnings
-891.71M -913.23M -936.57M -938M -952.35M -953.07M -942.32M -915.45M -902M -890.51M -864.3M -838.26M -829.27M -793.75M -756.12M -722.8M -672.54M -625.53M
Comprehensive Income
-905K -825K -647K -385K -859K -854K -730K -947K -1.02M -988K -1.06M -1.53M -1.85M -1.62M -852K -794K -792K -799K
Shareholders Equity
335.3M 350.19M 377.48M 388M 364.62M 359.48M 377.95M 391.88M 392.29M 390.41M 405.44M 423.43M 423.77M 448.12M 479.09M 298.17M 332.26M 370.23M
Total Investments
262.13M 246.47M 275.04M 311.61M 297.27M 255.65M 301.81M 292.09M 269.01M 295.22M 295.22M 290.59M 240.1M 286.21M 234.18M 228.81M 202.18M 204.27M